![Vincent van Houten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincent van Houten
Directeur/Membre du Conseil chez
Oxitope Pharma BV
Profil
Vincent van Houten is currently Director at Forbion Capital Fund III Coöperatief UA and Director at Oxitope Pharma BV.
Formerly, Mr. van Houten was Chief Financial Officer at Forbion Capital Partners Management Holding BV from 2016 to 2025 and Chief Financial Officer at Biogeneration Management BV.
Postes actifs de Vincent van Houten
| Sociétés | Poste | Début |
|---|---|---|
Oxitope Pharma BV
 Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases | Directeur/Membre du Conseil | - |
Forbion Capital Fund III Coöperatief UA
 Forbion Capital Fund III Coöperatief UA Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | - |
Anciens postes connus de Vincent van Houten
| Sociétés | Poste | Fin |
|---|---|---|
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Directeur Financier/CFO | 31/12/2025 |
Biogeneration Management BV
 Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
Forbion Capital Fund III Coöperatief UA
Forbion Capital Fund III Coöperatief UA Investment ManagersFinance Functions as an alternative investment manager | Finance |
Oxitope Pharma BV
Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases | Health Technology |
